0
1. 5. 2019.
PCN206 PATIENT-REPORTED REAL-WORLD TREATMENT PATTERNS FOR MELANOMA IN THE UK MEASURED USING A DIGITAL 'BRING YOUR OWN DEVICE' PLATFORM
New treatments in melanoma are gradually transforming the disease into a chronic condition: • for advanced disease stages, the median survival has significantly increased (from 9 months in stage 4 patients with limited treatment options,3 to a 3-year survival rate of up to 58%, with a proportion of them living to 5-10 years.4 • in the early setting, adjuvant therapy is taking a prominent place in the therapeutic landscape, with many patients with normal life expectancies being exposed to treatments with potential side effects (some long-term or irreversible).5